Qualitative comparison of the results of the ISS T-002 Clinical Trial and the ISS OBS T-002 Observational Study up to 48 weeks of follow-up: activation markers, T-regs, cell viability and lymphocyte phenotype.

aSubjects enrolled in the clinical trial; bsubjects enrolled in the OBS study with the same characteristics at baseline of the trial patients; c all evaluable subjects enrolled in the OBS study. Shown are the qualitative changes from baseline of the different study populations for all evaluated parameters. +, increase; −, decrease; +/−, fluctuations (higher and lower levels as compared to baseline at different time points);  =  stable; (∗), statistically significant in at least one time point; n.d., not done.